Skip to content

HealthUnited States5 min read

FDA Approves Bemotrizinol: New Sunscreen Ingredient for US

FDA greenlights bemotrizinol, a new broad-spectrum sunscreen ingredient, for the U.S. market. The first addition in 25+ years, it offers superior UV protection. Get details.

Share

Topics

Sign for the U.S. Department of Health and Human Services and the FDA, with official seals and a blue FDA logo on a gray monument.

FDA approves bemotrizinol for U.S. sunscreens — first new active ingredient in more than 25 years

The FDA has approved bemotrizinol for U.S. sunscreens — the first new active ingredient in more than 25 years — classifying it GRASE for ages six months and up, with products sold as Parsol Shield expected in 2026.

  • New GRASE filter: Bemotrizinol (BEMT) permitted up to 6% in OTC sunscreens — the first Category 1 addition in over 25 years (FDA press announcement).
  • Internationally proven: A modern, photostable broad‑spectrum UVA/UVB filter already used in Europe and Asia (peer-reviewed review).
  • Parsol Shield rollout: DSM plans a 2026 U.S. launch under the Parsol Shield brand with an 18‑month exclusivity before wider manufacturer access.

What the FDA did and why it matters

The FDA expanded the OTC sunscreen monograph to include bemotrizinol (BEMT) and classified it as Generally Recognized as Safe and Effective (GRASE) for adults and children 6 months and older at concentrations up to 6%. This change brings the U.S. closer to international practice by allowing a modern chemical filter that offers robust UVA and UVB protection. The decision relied on data showing strong photostability, low irritation, and minimal systemic absorption (FDA press announcement; peer-reviewed review).

Regulatory pathway and status

Bemotrizinol’s inclusion followed an Over‑the‑Counter Monograph Order Request (OMOR), a pathway that lets manufacturers submit modern safety and effectiveness data to update OTC monographs more quickly than the older process. DSM‑Firmenich (DSM Nutritional Products) submitted evidence to permit bemotrizinol at up to 6%, and the FDA’s Category 1 finding marks the first successful use of the updated OMOR pathway under current testing standards (analysis and background).

Product rollout, exclusivity and branding

DSM plans to market bemotrizinol in the U.S. as Parsol Shield. Reports indicate an initial U.S. launch in 2026, with an 18‑month exclusivity window during which other manufacturers cannot use BEMT. After that period, other brands may incorporate the filter. The U.S. 6% cap aligns with Canada but is lower than the 10% limit used in the EU and elsewhere (review; FDA).

Safety, absorption and irritation profile

The FDA and independent studies indicate a favorable safety profile: low skin irritation, rare adverse events, and minimal systemic absorption. A pharmacokinetic study found blood levels seldom exceeded the FDA’s 0.5 ng/mL threshold used to assess systemic exposure, supporting the conclusion that bemotrizinol largely remains on or near the skin surface (review; FDA).

How bemotrizinol works and why dermatologists care

Bemotrizinol is a chemical UV filter that absorbs both UVA and UVB radiation and is highly photostable. Photostability reduces the need for stabilizers and helps maintain protection during sun exposure. Formulators call it a “team player” because it pairs well with other filters to broaden and stabilize protection, enabling lighter, more cosmetically pleasing sunscreens with solid UVA coverage (review).

“Bemotrizinol pairs well with other filters to broaden and stabilize protection,” says formulators and dermatology reviewers familiar with international usage.

Context: U.S. sunscreen regulation and why this took so long

Before this action, the U.S. had not added a new Category 1 sunscreen active ingredient in more than 25 years. The legacy monograph process prevented many modern filters from entering the U.S. market while other countries updated lists. Public health experts and dermatologists pushed for modernization; OMOR is designed to reduce regulatory inertia if manufacturers supply robust safety and maximal usage trial (MUsT) data (background and analysis; FDA OTC FAQs).

Practical implications for consumers

When Parsol Shield and other bemotrizinol sunscreens reach stores, shoppers should see products with more stable UVA protection — important for reducing photoaging and contributing to long‑term skin cancer prevention when used correctly. Consumers should continue established sun‑safety practices: use broad‑spectrum sunscreen with SPF 15 or higher (SPF 30 recommended for extended outdoor time), apply generously, reapply every two hours and after swimming, wear protective clothing, and limit sun exposure during peak hours (FDA guidance).

Relation to other advanced filters and future outlook

Bemotrizinol joins other modern filters long used abroad — for example, bisoctrizole and drometrizole trisiloxane — narrowing the gap between U.S. and international sunscreen options. The OMOR pathway used here may facilitate additional updates if companies provide comprehensive safety and usage data. FDA officials have signaled intent to modernize regulation so Americans gain access to consumer‑friendly, safe sunscreens more quickly (FDA press announcement).

Source notes and further reading

Implications for San Luis Obispo, California

Economic impact

San Luis Obispo’s retail shops, pharmacies and resort supply stores may see new product demand when Parsol Shield and later bemotrizinol formulas arrive. Local businesses that sell sunscreens — surf shops, outdoor outfitters and drugstores — could benefit from fresh inventory attractive to beachgoers and outdoor workers.

Health and social effects

County residents and visitors who spend time on beaches, trails and vineyards may gain access to sunscreens offering stronger, longer‑lasting UVA protection. That may help reduce sunburn, photoaging and long‑term skin cancer risk when products are used correctly. Local clinics and dermatologists can inform patients about new options and reinforce sunscreen-plus strategies.

Political and regulatory consequences

The FDA action can inform local conversations about sun‑safety standards in county health programs and schools. Public health officials may update educational materials on filter chemistry and reiterate application guidance; policymakers may cite the change when revising workplace safety or recreational facility guidelines.

Cultural relevance and practical applications

San Luis Obispo’s outdoor culture — from surfing to farmers markets and vineyard visits — could see higher sunscreen uptake if new products are cosmetically pleasant and non‑greasy. Local salons, outdoor clubs and the county parks department can promote availability and correct use during community events.

Where to look and what to expect locally

Parsol Shield products are expected in 2026, initially sold under DSM’s brand and then accessible to other manufacturers after an 18‑month exclusivity. When shopping locally, look for active ingredient lists that include bemotrizinol (BEMT), check labels for “broad‑spectrum” and SPF rating, and follow FDA guidance on amount and frequency of application (FDA).

For more details and full source notes, see the links above.

Share

Topics

Kevin Morgan

Kevin Morgan is a senior food and dining writer for Times Media Service, based in Los Angeles, California. Morgan covers food and dining, along with sports and health, bringing an evidence-based, community-focused approach to health reporting. Morgan holds a master's degree in sport administration and grew up in Canton, Ohio.

Write to Kevin